Operating Income

Gross Profit

STERIS Gross Profit increased by 1.5% to $655.50M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 7.4%, from $610.40M to $655.50M. Over 3 years (FY 2022 to FY 2025), Gross Profit shows an upward trend with a 6.0% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementIncome Statement
SectionOperating Income
CategoryProfitability
SignalHigher is better
VolatilityStable
First reportedQ1 2014
Last reportedQ1 2026

How to read this metric

An increase suggests improved manufacturing efficiency, favorable product mix, or higher pricing power, while a decrease may indicate rising raw material costs, supply chain inefficiencies, or competitive pricing pressure.

Detailed definition

Gross profit represents the residual earnings a company retains after deducting the direct costs associated with produci...

Peer comparison

Peers in the medical device and diagnostics sector typically maintain high gross margins due to intellectual property and specialized manufacturing, though these vary based on the specific product mix of nutritionals versus high-tech devices.

Metric ID: gross_profit

Historical Data

19 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Value$426.28M$480.34M$538.11M$571.62M$473.83M$482.31M$478.19M$546.40M$529.00M$546.23M$560.03M$582.90M$572.40M$578.80M$610.40M$641.16M$628.00M$645.90M$655.50M
QoQ Change+12.7%+12.0%+6.2%-17.1%+1.8%-0.9%+14.3%-3.2%+3.3%+2.5%+4.1%-1.8%+1.1%+5.5%+5.0%-2.1%+2.9%+1.5%
YoY Change+11.2%+0.4%-11.1%-4.4%+11.6%+13.3%+17.1%+6.7%+8.2%+6.0%+9.0%+10.0%+9.7%+11.6%+7.4%
Range$426.28M$655.50M
CAGR+10.0%
Avg YoY Growth+7.1%
Median YoY Growth+9.0%
Current Streak2 quarters growth

Frequently Asked Questions

What is STERIS's gross profit?
STERIS (STE) reported gross profit of $655.50M in Q4 2025.
How has STERIS's gross profit changed year-over-year?
STERIS's gross profit increased by 7.4% year-over-year, from $610.40M to $655.50M.
What is the long-term trend for STERIS's gross profit?
Over 3 years (2022 to 2025), STERIS's gross profit has grown at a 6.0% compound annual growth rate (CAGR), from $2.02B to $2.40B.
What does gross profit mean?
The total revenue earned from sales minus the direct costs required to manufacture and deliver those products.